Global Non-Invasive Prenatal Testing (NIPT) Market Outlook 2037

The global non-invasive prenatal testing (NIPT) market size is projected to reach a CAGR of 9.4% during the forecast period, 2025-2037. Factors driving the demand for non-invasive prenatal testing include the rising maternal age and growing awareness regarding genetic anomalies, coupled with technological advancements made in genome sequencing techniques. Government initiatives and updates in prenatal screening guidelines will further drive market share. The market is projected to capture revenue worth USD 14.59 billion by the end of 2037 from a recorded revenue of USD 4.53 billion in 2024.

1. Study Objective

1.1. Market Definition
1.2. Market Segmentation

2. Assumptions and Abbreviations

3. Research Process

3.1. SPSS Methodology
3.2. Primary Research
3.2.1. Manufacturers
3.2.2. End Users
3.3. Secondary Research
3.4. Market Size Estimation

4. Executive Summary5. Opportunities6. Growth Drivers7. Major Roadblocks8. Trends9. Government Regulation: How They Would Aid Business?10. Up-Coming Technologies11. Growth Outlook12. Risk Analysis13. SWOT14. Merger and Acquisitions15. Application Analysis16. Regional Demand17. Recent News18. Technology Analysis19. End User Analysis20. Non-Invasive Prenatal Testing (NIPT) Uptake by Pregnancy Risk Level Analysis21. Comparative Positioning

22. Competitive Landscape: Global Key Players

22.1. Company Market Share
22.2. Business Profile of Key Enterprise
22.2.1. Centogene N.V.
22.2.1.1. Detailed Overview
22.2.1.2. Assessment of key offerings
22.2.1.3. Analysis of growth strategies
22.2.1.4. Exhaustive analysis on key financial indicators
22.2.1.5. Recent developments and strategies
22.2.2. CRIFM Prenatal Medical Clinic
22.2.3. Eurofins LifeCodexx GmbH
22.2.4. MedGenome Labs Ltd.
22.2.5. NIPT Hiro Clinic
22.2.6. FALCO biosystems Ltd.
22.2.7. Biora Therapeutics,Inc.(Progenity,Inc.)
22.2.8. F. Hoffmann-La Roche Ltd.
22.2.9. Illumina Inc.
22.2.10. Laboratory Corporation of America Holdings.
22.2.11. Natera Inc.
22.2.12. Myriad Women’s Health, Inc.
22.2.13. QIAGEN
22.2.14. Quest Diagnostics
22.2.15. CooperSurgical, Inc.

23. Global Non-Invasive Prenatal Testing (NIPT) Market Outlook

23.1. Market Overview
23.2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
23.3. Global Non-Invasive Prenatal Testing (NIPT) Market Segmentation Analysis (2024-2037)
23.3.1. By Gestational Age
23.3.1.1. 0-12 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
23.3.1.2. 13-24 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
23.3.1.3. 25-36 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
23.3.2. By Pregnancy Risk
23.3.2.1. High risk vs. average risk, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
23.3.2.2. Low-risk Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
23.3.3. By Method
23.3.3.1. Biochemical Screening Tests, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
23.3.3.2. Maternal cell-free DNA, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
23.3.3.3. Plasma Testing, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
23.3.3.4. Ultrasonic Detection, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
23.3.4. By Technology
23.3.4.1. Next-generation sequencing (NGS), Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
23.3.4.2. Array Technology, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
23.3.4.3. Polymerase Chain Reaction (PCR), Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
23.3.5. By Product
23.3.5.1. Consumables and Reagents, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
23.3.5.2. Device, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
23.3.6. By Application
23.3.6.1. Trisomy, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
23.3.6.2. Microdeletion syndromes, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
23.3.6.3. Others, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
23.3.7. By End user
23.3.7.1. Hospitals and Clinics, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
23.3.7.2. Diagnostic Laboratories, Market Value (USD Million), and CAGR, 2024-2037F
23.3.8. By Region
23.3.8.1. North America Market Value (USD Million), and CAGR, 2024-2037F
23.3.8.2. Europe Market Value (USD Million), and CAGR, 2024-2037F
23.3.8.3. Asia Pacific Excluding Japan Market Value (USD Million), and CAGR, 2024-2037F
23.3.8.4. Japan Market Value (USD Million), and CAGR, 2024-2037F
23.3.8.5. Latin America Market Value (USD Million), and CAGR, 2024-2037F
23.3.8.6. Middle East and Africa Market Value (USD Million), and CAGR, 2024-2037F

Cross Analysis of End User W.R.T. Technology (USD Million), 2024-2037

24. North America Non-Invasive Prenatal Testing (NIPT) Market Outlook

24.1. Market Overview
24.2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
24.3. North America Non-Invasive Prenatal Testing (NIPT) Market Segmentation Analysis (2024-2037)
24.3.1. By Gestational Age
24.3.1.1. 0-12 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
24.3.1.2. 13-24 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
24.3.1.3. 25-36 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
24.3.2. By Pregnancy Risk
24.3.2.1. High risk vs. average risk, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
24.3.2.2. Low-risk Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
24.3.3. By Method
24.3.3.1. Biochemical screening tests, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
24.3.3.2. Maternal cell-free DNA, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
24.3.3.3. Plasma testing, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
24.3.3.4. Ultrasonic Detection, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
24.3.4. By Technology
24.3.4.1. Next-generation sequencing (NGS), Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
24.3.4.2. Array Technology, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
24.3.4.3. Polymerase Chain Reaction (PCR), Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
24.3.5. By Product
24.3.5.1. Consumables and Reagents, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
24.3.5.2. Device, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
24.3.6. By Application
24.3.6.1. Trisomy, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
24.3.6.2. Microdeletion syndromes, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
24.3.6.3. Others, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
24.3.7. By End user
24.3.7.1. Hospitals and Clinics, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
24.3.7.2. Diagnostic Laboratories, Market Value (USD Million), and CAGR, 2024-2037F
24.3.8. By Country
24.3.8.1. US Market Value (USD Million), and CAGR, 2024-2037F
24.3.8.2. Canada Market Value (USD Million), and CAGR, 2024-2037F

Cross Analysis of End User W.R.T. Technology (USD Million), 2024-2037

25. Europe Non-Invasive Prenatal Testing (NIPT) Market Outlook

25.1. Market Overview
25.2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
25.3. Europe Non-Invasive Prenatal Testing (NIPT) Market Segmentation Analysis (2024-2037)
25.3.1. By Gestational Age
25.3.1.1. 0-12 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
25.3.1.2. 13-24 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
25.3.1.3. 25-36 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
25.3.2. By Pregnancy Risk
25.3.2.1. High risk vs. average risk, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
25.3.2.2. Low-risk Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
25.3.3. By Method
25.3.3.1. Biochemical screening tests, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
25.3.3.2. Maternal cell-free DNA, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
25.3.3.3. Plasma testing, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
25.3.3.4. Ultrasonic Detection, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
25.3.4. By Technology
25.3.4.1. Next-generation sequencing (NGS), Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
25.3.4.2. Array Technology, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
25.3.4.3. Polymerase Chain Reaction (PCR), Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
25.3.5. By Product
25.3.5.1. Consumables and Reagents, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
25.3.5.2. Device, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
25.3.6. By Application
25.3.6.1. Trisomy, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
25.3.6.2. Microdeletion syndromes, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
25.3.6.3. Others, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
25.3.7. By End User
25.3.7.1. Hospitals and Clinics, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
25.3.7.2. Diagnostic Laboratories, Market Value (USD Million), and CAGR, 2024-2037F
25.3.8. By Country
25.3.8.1. UK Market Value (USD Million), and CAGR, 2024-2037F
25.3.8.2. Germany Market Value (USD Million), and CAGR, 2024-2037F
25.3.8.3. France Market Value (USD Million), and CAGR, 2024-2037F
25.3.8.4. Italy Market Value (USD Million), and CAGR, 2024-2037F
25.3.8.5. Spain Market Value (USD Million), and CAGR, 2024-2037F
25.3.8.6. BENELUX Market Value (USD Million), and CAGR, 2024-2037F
25.3.8.7. Poland Market Value (USD Million), and CAGR, 2024-2037F
25.3.8.8. Russia Market Value (USD Million), and CAGR, 2024-2037F
25.3.8.9. Rest of Europe Market Value (USD Million), and CAGR, 2024-2037F

Cross Analysis of End User W.R.T. Technology (USD Million), 2024-2037

26. Asia Pacific excluding Japan Non-Invasive Prenatal Testing (NIPT) Market Outlook

26.1. Market Overview
26.2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
26.3. Asia Pacific excluding Japan Non-Invasive Prenatal Testing (NIPT) Market Segmentation Analysis (2024-2037)
26.3.1. By Gestational Age
26.3.1.1. 0-12 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
26.3.1.2. 13-24 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
26.3.1.3. 25-36 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
26.3.2. By Pregnancy Risk
26.3.2.1. High risk vs. average risk, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
26.3.2.2. Low-risk Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
26.3.3. By Method
26.3.3.1. Biochemical screening tests, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
26.3.3.2. Maternal cell-free DNA, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
26.3.3.3. Plasma testing, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
26.3.3.4. Ultrasonic Detection, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
26.3.4. By Technology
26.3.4.1. Next-generation sequencing (NGS), Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
26.3.4.2. Array Technology, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
26.3.4.3. Polymerase Chain Reaction (PCR), Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
26.3.5. By Product
26.3.5.1. Consumables and Reagents, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
26.3.5.2. Device, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
26.3.6. By Application
26.3.6.1. Trisomy, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
26.3.6.2. Microdeletion syndromes, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
26.3.6.3. Others, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
26.3.7. By End User
26.3.7.1. Hospitals and Clinics, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
26.3.7.2. Diagnostic Laboratories, Market Value (USD Million), and CAGR, 2024-2037F
26.3.8. By Country
26.3.8.1. China Market Value (USD Million), and CAGR, 2024-2037F
26.3.8.2. India Market Value (USD Million), and CAGR, 2024-2037F
26.3.8.3. ASEAN, Market Value (USD Million), and CAGR, 2024-2037F
26.3.8.4. South Korea Market Value (USD Million), and CAGR, 2024-2037F
26.3.8.5. Australia Market Value (USD Million), and CAGR, 2024-2037F
26.3.8.6. New Zealand Market Value (USD Million), and CAGR, 2024-2037F
26.3.8.7. Rest of Asia Pacific excluding Japan Market Value (USD Million), and CAGR, 2024-2037F

Cross Analysis of End User W.R.T. Technology (USD Million), 2024-2037

27. Japan Non-Invasive Prenatal Testing (NIPT) Market Outlook

27.1. Market Overview
27.2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
27.3. Japan Non-Invasive Prenatal Testing (NIPT) Market Segmentation Analysis (2024-2037)
27.3.1. By Gestational Age
27.3.1.1. 0-12 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
27.3.1.2. 13-24 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
27.3.1.3. 25-36 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
27.3.2. By Pregnancy Risk
27.3.2.1. High risk vs. average risk, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
27.3.2.2. Low-risk Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
27.3.3. By Method
27.3.3.1. Biochemical screening tests, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
27.3.3.2. Maternal cell-free DNA, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
27.3.3.3. Plasma Testing, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
27.3.3.4. Ultrasonic Detection, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
27.3.4. By Technology
27.3.4.1. Next-generation sequencing (NGS), Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
27.3.4.2. Array Technology, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
27.3.4.3. Polymerase Chain Reaction (PCR), Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
27.3.5. By Product
27.3.5.1. Consumables and Reagents, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
27.3.5.2. Device, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
27.3.6. By Application
27.3.6.1. Trisomy, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
27.3.6.2. Microdeletion syndromes, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
27.3.6.3. Others, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
27.3.7. By End User
27.3.7.1. Hospitals and Clinics, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
27.3.7.2. Diagnostic Laboratories, Market Value (USD Million), and CAGR, 2024-2037F

Cross Analysis of End User W.R.T. Technology (USD Million), 2024-2037

28. Latin America Non-Invasive Prenatal Testing (NIPT) Market Outlook

28.1. Market Overview
28.2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
28.3. Latin America Non-Invasive Prenatal Testing (NIPT) Market Segmentation Analysis (2024-2037)
28.3.1. By Gestational Age
28.3.1.1. 0-12 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
28.3.1.2. 13-24 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
28.3.1.3. 25-36 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
28.3.2. By Pregnancy Risk
28.3.2.1. High risk vs. average risk, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
28.3.2.2. Low-risk Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
28.3.3. By Method
28.3.3.1. Biochemical screening tests, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
28.3.3.2. Maternal cell-free DNA, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
28.3.3.3. Plasma testing, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
28.3.3.4. Ultrasonic Detection, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
28.3.4. By Technology
28.3.4.1. Next-generation sequencing (NGS), Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
28.3.4.2. Array Technology, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
28.3.4.3. Polymerase Chain Reaction (PCR), Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
28.3.5. By Product
28.3.5.1. Consumables and Reagents, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
28.3.5.2. Device, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
28.3.6. By Application
28.3.6.1. Trisomy, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
28.3.6.2. Microdeletion syndromes, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
28.3.6.3. Others, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
28.3.7. By End user
28.3.7.1. Hospitals and Clinics, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
28.3.7.2. Diagnostic Laboratories, Market Value (USD Million), and CAGR, 2024-2037F
28.3.8. By Country
28.3.8.1. Brazil Market Value (USD Million), and CAGR, 2024-2037F
28.3.8.2. Argentina Market Value (USD Million), and CAGR, 2024-2037F
28.3.8.3. Mexico Market Value (USD Million), and CAGR, 2024-2037F
28.3.8.4. Rest of Latin America Market Value (USD Million), and CAGR, 2024-2037F

Cross Analysis of End user W.R.T. Technology (USD Million), 2024-2037

29. Middle East & Africa Non-Invasive Prenatal Testing (NIPT) Market Outlook

29.1. Market Overview
29.2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
29.3. Middle East & Africa Non-Invasive Prenatal Testing (NIPT) Market Segmentation Analysis (2024-2037)
29.3.1. By Gestational Age
29.3.1.1. 0-12 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
29.3.1.2. 13-24 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
29.3.1.3. 25-36 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
29.3.2. By Pregnancy Risk
29.3.2.1. High risk vs. average risk, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
29.3.2.2. Low-risk Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
29.3.3. By Method
29.3.3.1. Biochemical screening tests, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
29.3.3.2. Maternal cell-free DNA, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
29.3.3.3. Plasma testing, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
29.3.3.4. Ultrasonic Detection, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
29.3.4. By Technology
29.3.4.1. Next-generation sequencing (NGS), Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
29.3.4.2. Array Technology, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
29.3.4.3. Polymerase Chain Reaction (PCR), Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
29.3.5. By Product
29.3.5.1. Consumables and Reagents, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
29.3.5.2. Device, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
29.3.6. By Application
29.3.6.1. Trisomy, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
29.3.6.2. Microdeletion syndromes, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
29.3.6.3. Others, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
29.3.7. By End user
29.3.7.1. Hospitals and Clinics, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
29.3.7.2. Diagnostic Laboratories, Market Value (USD Million), and CAGR, 2024-2037F
29.3.8. By Country
29.3.8.1. GCC Market Value (USD Million), and CAGR, 2024-2037F
29.3.8.2. Israel Market Value (USD Million), and CAGR, 2024-2037F
29.3.8.3. South Africa Market Value (USD Million), and CAGR, 2024-2037F
29.3.8.4. Rest of Middle East & Africa Market Value (USD Million), and CAGR, 2024-2037F

Cross Analysis of End User W.R.T. Technology (USD Million), 2024-2037

30. Global Economic Scenario

Companies Mentioned

Leading Players in the Global Non-Invasive Prenatal Testing (NIPT) Market include:

Illumina Inc.
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd.
Laboratory Corporation of America Holdings
Natera Inc.
Yourgene Health
Eurofins LifeCodexx GmbH
Quest Diagnostics Incorporated

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5449EUR$5,550USD£4,547GBP
Hard Copy	A printed copy of the product will be shipped to you.		€6431EUR$6,550USD£5,366GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€6431EUR$6,550USD£5,366GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€10359EUR$10,550USD£8,643GBP

Table of Contents

Companies Mentioned

Related Topics

Related Reports

Non-Invasive Prenatal Testing (NIPT) Market by Product & Service (Consumables (Assay Kits & Reagents), Instruments (NGS Systems, Microarrays)), Method (Biochemical Screening, Cell-Free DNA Test), End User (Diagnostic Labs) - Global Forecast to 2029

Non Invasive Prenatal Testing Market Size, Share & Trends Analysis Report by Gestation Period, Pregnancy Risk, Method, Technology, Product, Application, End-use, Region, and Segment Forecasts, 2024-2030

Non invasive Prenatal Testing - Market Insights, Competitive Landscape, and Market Forecast - 2030

Non-Invasive Prenatal Testing (NIPT) - Global Strategic Business Report

Non-invasive Prenatal Testing Global Market Report 2024